Advertisement

Innovative Approaches in the Delivery of Eye Care: Children

  • Rohit C. KhannaEmail author
  • Maria Vittoria Cicinelli
  • Vijaya K. Gothwal
  • Clare Gilbert
Chapter
Part of the Essentials in Ophthalmology book series (ESSENTIALS)

Abstract

The control of blindness in children is a high priority for VISION2020. However, demographic differences and variation in levels of socioeconomic development, both of which influence the epidemiology of blindness in children, vary from country to country. This means that each country needs to understand the leading causes of blindness and visual impairment and develop appropriate strategies for control. This chapter highlights some models for eye care delivery in children especially regarding uncorrected refractive error (URE), congenital and developmental cataract, and retinopathy of prematurity (ROP) as well as for low vision and rehabilitation.

Keywords

Childhood blindness Uncorrected refractive error Retinopathy of prematurity Childhood cataract Low vision Rehabilitation Comprehensive eye care 

Notes

Acknowledgement

We are most grateful to Dr Rahul Ali, Hasan Minto, Dr Andrea Zin, Dr Subhadra Jalali, Dr Anand Vinekar and Dr Paul Courtright for their contribution to different sections in this chapter.

References

  1. 1.
    WHO launches Vision 2020 to combat avoidable blindness. Public Health Rep. 1999;114:210.Google Scholar
  2. 2.
  3. 3.
    Last accessed 11th Mar 2018b. https://www.ourchildrensvision.org/.
  4. 4.
    Last accessed 11th Mar 2018c. https://www.peekvision.org/.
  5. 5.
    Agarwal PK, Bowman R, Courtright P. Child eye health tertiary facilities in Africa. J AAPOS. 2010;14:263–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Aghaji AE, Ezegwui IR, Shiweobi JO, Mamah CC, Okoloagu MN, Onwasigwe EN. Using key informant method to determine the prevalence and causes of childhood blindness in South-Eastern Nigeria. Ophthalmic Epidemiol. 2017;24:401–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Akman I, Demirel U, Yenice O, Ilerisoy H, Kazokoglu H, Ozek E. Screening criteria for retinopathy of prematurity in developing countries. Eur J Ophthalmol. 2010;20:931–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Al-Ghamdi A, Albiani DA, Hodge WG, Clarke WN. Myopia and astigmatism in retinopathy of prematurity after treatment with cryotherapy or laser photocoagulation. Can J Ophthalmol. 2004;39:521–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Asferaw M, Woodruff G, Gilbert C. Causes of severe visual impairment and blindness in students in schools for the blind in Northwest Ethiopia. BMJ Glob Health. 2017;2:e000264.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35–49.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Chandna A, Gilbert C. When your eye patient is a child. Commun Eye Health. 2010;23(72):1–3.Google Scholar
  12. 12.
    Chavda S, Hodge W, Si F, Diab K. Low-vision rehabilitation methods in children: a systematic review. Can J Ophthalmol. 2014;49:e71–3.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology. 2012;119:347–54.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Chia A, Chua WH, Wen L, Fong A, Goon YY, Tan D. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157:451–7. e1PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Congdon NG, Ruiz S, Suzuki M, Herrera V. Determinants of pediatric cataract program outcomes and follow-up in a large series in Mexico. J Cataract Refract Surg. 2007;33:1775–80.PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Courtright P, Hutchinson AK, Lewallen S. Visual impairment in children in middle- and lower-income countries. Arch Dis Child. 2011;96:1129–34.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Darlow BA, Gilbert CE, Quiroga AM. Setting up and improving retinopathy of prematurity programs: interaction of neonatology, nursing, and ophthalmology. Clin Perinatol. 2013;40:215–27.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Dave VP, Jalali S, Rani PK, Padhi TR. Characteristics and outcomes of anterior hyaloidal fibrovascular proliferation in lasered retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Study (ITCROPS) report number 4. Int Ophthalmol. 2014;34:511–7.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Davitt BV, Dobson V, Good WV, Hardy RJ, Quinn GE, Siatkowski RM, Summers CG, Tung B, Early Treatment for Retinopathy of Prematurity Cooperative, G. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity. Ophthalmology. 2005;112:1564–8.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Demissie BS, Solomon AW. Magnitude and causes of childhood blindness and severe visual impairment in Sekoru District, Southwest Ethiopia: a survey using the key informant method. Trans R Soc Trop Med Hyg. 2011;105:507–11.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Du Toit R, Courtright P, Lewallen S. The use of key informant method for identifying children with blindness and severe visual impairment in developing countries. Ophthalmic Epidemiol. 2017;24:153–67.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Eriksen JR, Bronsard A, Mosha M, Carmichael D, Hall A, Courtright P. Predictors of poor follow-up in children that had cataract surgery. Ophthalmic Epidemiol. 2006;13:237–43.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Evans CT, Lenhart PD, Lin D, Yang Z, Daya T, Kim YM, Seneadza A, Mboni C, Msukwa G, Lewallen S, Courtright P. A cost analysis of pediatric cataract surgery at two child eye health tertiary facilities in Africa. J AAPOS. 2014;18:559–62.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Foster A, Gilbert C. Epidemiology of childhood blindness. Eye (Lond). 1992;6(Pt 2):173–6.CrossRefGoogle Scholar
  25. 25.
    Foster A, Gilbert C, Rahi J. Epidemiology of cataract in childhood: a global perspective. J Cataract Refract Surg. 1997;23(Suppl 1):601–4.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Ganesh S, Sethi S, Srivastav S, Chaudhary A, Arora P. Impact of low vision rehabilitation on functional vision performance of children with visual impairment. Oman J Ophthalmol. 2013;6:170–4.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA, Group, B.-R. C. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 2014;132:1327–33.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77–82.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Gilbert C, Bowman R, Malik AN. The epidemiology of blindness in children: changing priorities. Commun Eye Health. 2018;30:74–7.Google Scholar
  30. 30.
    Gilbert C, Foster A. Childhood blindness in the context of VISION 2020 – the right to sight. Bull World Health Organ. 2001;79:227–32.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Gilbert C, Rahi J, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350:12–4.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Gilbert CE, Lepvrier-Chomette N. Gender inequalities in surgery for bilateral cataract among children in low-income countries: a systematic review. Ophthalmology. 2016;123:1245–51.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Gogate P, Deshpande M, Sudrik S, Taras S, Kishore H, Gilbert C. Changing pattern of childhood blindness in Maharashtra, India. Br J Ophthalmol. 2007;91:8–12.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Gogate P, Dole K, Ranade S, Deshpande M. Cost of pediatric cataract surgery in Maharashtra, India. Int J Ophthalmol. 2010a;3:182–6.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Gogate P, Gilbert C. Clinical and cost impact of a pediatric cataract follow-up program in Western Nepal and adjacent northern Indian states. J AAPOS. 2015;19:94.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Gogate P, Khandekar R, Shrishrimal M, Dole K, Taras S, Kulkarni S, Ranade S, Deshpande M. Delayed presentation of cataracts in children: are they worth operating upon? Ophthalmic Epidemiol. 2010b;17:25–33.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Gogate P, Muhit M. Blindness and cataract in children in developing countries. Commun Eye Health. 2009;22:4–5.Google Scholar
  38. 38.
    Gogate P, Parbhoo D, Ramson P, Budhoo R, Overland L, Mkhize N, Naidoo K, Levine S, Du Bryn A, Benjamin L. Surgery for sight: outcomes of congenital and developmental cataracts operated in Durban, South Africa. Eye (Lond). 2016;30:1523–4.CrossRefGoogle Scholar
  39. 39.
    Gogate P, Patil S, Kulkarni A, Mahadik A, Tamboli R, Mane R, Borah R, Rao GV. Barriers to follow-up for pediatric cataract surgery in Maharashtra, India: how regular follow-up is important for good outcome. The Miraj Pediatric Cataract Study II. Indian J Ophthalmol. 2014;62:327–32.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Gothwal VK, Sumalini R, Bharani S. Assessing the effectiveness of low vision rehabilitation in children: an observational study. Invest Ophthalmol Vis Sci. 2015;56:3355–60.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Hammond CJ, Snieder H, Gilbert CE, Spector TD. Genes and environment in refractive error: the twin eye study. Invest Ophthalmol Vis Sci. 2001;42:1232–6.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Hariharan L, Gilbert CE, Quinn GE, Barg FK, Lomuto C, Quiroga A, McLeod-Omawale J, Zin A, Ortiz Z, Alda E, Bouzas L, Brussa M, Cattaino A, Dinerstein A, Erpen N, Fandiño A, Galina L, Manzitti J, Marinaro S, Sepúlveda T, Visintín P, Silva JC, Magluta C, Benitez A. Reducing blindness from retinopathy of prematurity (ROP) in Argentina through collaboration, advocacy and policy implementation. Health Policy Plan. 2018;33(5):654–65.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    He M, Xiang F, Zeng Y, Mai J, Chen Q, Zhang J, Smith W, Rose K, Morgan IG. Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial. JAMA. 2015;314:1142–8.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Jalali S, Anand R, Kumar H, Dogra MR, Azad R, Gopal L. Programme planning and screening strategy in retinopathy of prematurity. Indian J Ophthalmol. 2003;51:89–99.PubMedGoogle Scholar
  46. 46.
    Jalali S, Anand R, Rani PK, Balakrishnan D. Impact of the day-30 screening strategy on the disease presentation and outcome of retinopathy of prematurity. The Indian twin cities retinopathy of prematurity report number 3. Indian J Ophthalmol. 2014;62:610–4.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Jalali S, Azad R, Trehan HS, Dogra MR, Gopal L, Narendran V. Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol. 2010;58:509–15.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Jalali S, Kesarwani S, Hussain A. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2. Am J Ophthalmol. 2011;151:719–24. e2PubMedCrossRefGoogle Scholar
  49. 49.
    Jalali S, Matalia J, Hussain A, Anand R. Modification of screening criteria for retinopathy of prematurity in India and other middle-income countries. Am J Ophthalmol. 2006;141:966–8.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Jayadev C, Vinekar A, Mohanachandra P, Desai S, Suveer A, Mangalesh S, Bauer N, Shetty B. Enhancing image characteristics of retinal images of aggressive posterior retinopathy of prematurity using a novel software, (RetiView). Biomed Res Int. 2015;2015:898197.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Khandekar R, Kishore H, Mansu RM, Awan H. The status of childhood blindness and functional low vision in the Eastern Mediterranean region in 2012. Middle East Afr J Ophthalmol. 2014;21:336–43.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Kishiki E, Shirima S, Lewallen S, Courtright P. Improving postoperative follow-up of children receiving surgery for congenital or developmental cataracts in Africa. J AAPOS. 2009;13:280–2.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Kishiki E, Van Dijk K, Courtright P. Strategies to improve follow-up of children after surgery for cataract: findings from Child Eye Health Tertiary Facilities in sub-Saharan Africa and South Asia. Eye (Lond). 2016;30:1234–41.CrossRefGoogle Scholar
  54. 54.
    Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16:501–7.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Ma X, Zhou Z, Yi H, Pang X, Shi Y, Chen Q, Meltzer ME, Le Cessie S, He M, Rozelle S, Liu Y, Congdon N. Effect of providing free glasses on children’s educational outcomes in China: cluster randomized controlled trial. BMJ. 2014;g5740:349.Google Scholar
  56. 56.
    Mafwiri MM, Kisenge R, Gilbert CE. A pilot study to evaluate incorporating eye care for children into reproductive and child health services in Dar-es-Salaam, Tanzania: a historical comparison study. BMC Nurs. 2014;13:15.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Matti AI, Pesudovs K, Daly A, Brown M, Chen CS. Access to low-vision rehabilitation services: barriers and enablers. Clin Exp Optom. 2011;94:181–6.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Mboni C, Gogate PM, Phiri A, Seneadza A, Ramson P, Manolakos-Tsehisi H, Musonda L, Benjamin L, Overland L. Outcomes of pediatric cataract surgery in the Copperbelt Province of Zambia. J Pediatr Ophthalmol Strabismus. 2016;53:311–7.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Mintz-Hittner HA, Geloneck MM. Review of effects of anti-VEGF treatment on refractive error. Eye Brain. 2016;8:135–40.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Mintz-Hittner HA, Geloneck MM, Chuang AZ. Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy. Ophthalmology. 2016;123:1845–55.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Morjaria P, Evans J, Murali K, Gilbert C. Spectacle wear among children in a school-based program for ready-made vs custom-made spectacles in India: a randomized clinical trial. JAMA Ophthalmol. 2017;135:527–33.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Muhit M, Gilbert C. A review of the epidemiology and control of childhood blindness. Trop Dr. 2003;33:197–201.Google Scholar
  63. 63.
    Muhit MA. Childhood cataract: home to hospital. Commun Eye Health. 2004;17:19–22.Google Scholar
  64. 64.
    Muhit MA, Shah SP, Gilbert CE, Hartley SD, Foster A. The key informant method: a novel means of ascertaining blind children in Bangladesh. Br J Ophthalmol. 2007;91:995–9.PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Mutlu FM, Sarici SU. Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol. 2013;6:228–36.PubMedPubMedCentralGoogle Scholar
  66. 66.
    Mutti DO, Mitchell GL, Moeschberger ML, Jones LA, Zadnik K. Parental myopia, near work, school achievement, and children’s refractive error. Invest Ophthalmol Vis Sci. 2002;43:3633–40.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Mwende J, Bronsard A, Mosha M, Bowman R, Geneau R, Courtright P. Delay in presentation to hospital for surgery for congenital and developmental cataract in Tanzania. Br J Ophthalmol. 2005;89:1478–82.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Odedra N, Wedner SH, Shigongo ZS, Nyalali K, Gilbert C. Barriers to spectacle use in Tanzanian secondary school students. Ophthalmic Epidemiol. 2008;15:410–7.PubMedPubMedCentralCrossRefGoogle Scholar
  69. 69.
    Oner V, Bulut A, Oruc Y, Ozgur G. Influence of indoor and outdoor activities on progression of myopia during puberty. Int Ophthalmol. 2016;36:121–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt. 2012;32:3–16.PubMedCrossRefGoogle Scholar
  71. 71.
    Pearce MG. Clinical outcomes following the dispensing of ready-made and recycled spectacles: a systematic literature review. Clin Exp Optom. 2014;97:225–33.PubMedCrossRefGoogle Scholar
  72. 72.
    Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, Good WV, Early Treatment for Retinopathy of Prematurity Cooperative, G. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology. 2008;115:1058–64. e1PubMedCrossRefGoogle Scholar
  73. 73.
    Rai SK, Thapa H, Kandel RP, Ishaq M, Bassett K. Clinical and cost impact of a pediatric cataract follow-up program in western Nepal and adjacent northern Indian States. J AAPOS. 2014;18:67–70.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Rani PK, Balakrishnanan D, Padhi TR, Jalali S. Role of retinopathy of prematurity (ROP) tertiary centers of excellence in capacity-building. Indian Pediatr. 2016;53(Suppl 2):S85–8.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Rao GN, Khanna RC, Athota SM, Rajshekar V, Rani PK. Integrated model of primary and secondary eye care for underserved rural areas: the L V Prasad Eye Institute experience. Indian J Ophthalmol. 2012;60:396–400.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ. 2008;86:63–70.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Kulkarni S, Gilbert C. Blinding retinopathy of prematurity in western India: characteristics of children, reasons for late presentation and impact on families: a case series with indepth interviews. Ind Peds. 2018. https://indianpediatrics.net/aug2018/665.pdf.
  78. 78.
    Sankar MJ, Sankar J, Mehta M, Bhat V, Srinivasan R. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev. 2016;2:CD009734.PubMedPubMedCentralGoogle Scholar
  79. 79.
    Schulze Schwering M, Finger RP, Barrows J, Nyrenda M, Kalua K. Barriers to uptake of free pediatric cataract surgery in Malawi. Ophthalmic Epidemiol. 2014;21:138–43.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Sharma A, Congdon N, Patel M, Gilbert C. School-based approaches to the correction of refractive error in children. Surv Ophthalmol. 2012;57:272–83.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Sohaila A, Tikmani SS, Khan IA, Atiq H, Akhtar AS, Kumar P, Kumar K. Frequency of retinopathy of prematurity in premature neonates with a birth weight below 1500 grams and a gestational age less than 32 weeks: a study from a tertiary care hospital in a lower-middle income country. PLoS One. 2014;9:e100785.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Solebo AL, Cumberland PM, Rahi JS. Whole-population vision screening in children aged 4-5 years to detect amblyopia. Lancet. 2015;385:2308–19.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Solebo AL, Rahi J. Epidemiology, aetiology and management of visual impairment in children. Arch Dis Child. 2014a;99:375–9.PubMedCrossRefPubMedCentralGoogle Scholar
  84. 84.
    Solebo AL, Rahi JS. Vision screening in children: why and how? Ophthalmic Epidemiol. 2014b;21:207–9.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Solebo AL, Teoh L, Rahi J. Epidemiology of blindness in children. Arch Dis Child. 2017;102:853–7.PubMedCrossRefPubMedCentralGoogle Scholar
  86. 86.
    Sun HP, Li A, Xu Y, Pan CW. Secular trends of reduced visual acuity from 1985 to 2010 and disease burden projection for 2020 and 2030 among primary and secondary school students in China. JAMA Ophthalmol. 2015;133:262–8.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Tumwesigye C, Msukwa G, Njuguna M, Shilio B, Courtright P, Lewallen S. Inappropriate enrollment of children in schools for the visually impaired in east Africa. Ann Trop Paediatr. 2009;29:135–9.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Vinekar A, Avadhani K, Dogra M, Sharma P, Gilbert C, Braganza S, Shetty B. A novel, low-cost method of enrolling infants at risk for retinopathy of prematurity in centers with no screening program: the REDROP study. Ophthalmic Epidemiol. 2012;19:317–21.PubMedCrossRefPubMedCentralGoogle Scholar
  89. 89.
    Vinekar A, Gilbert C, Dogra M, Kurian M, Shainesh G, Shetty B, Bauer N. The KIDROP model of combining strategies for providing retinopathy of prematurity screening in underserved areas in India using wide-field imaging, tele-medicine, non-physician graders and smart phone reporting. Indian J Ophthalmol. 2014;62:41–9.PubMedPubMedCentralCrossRefGoogle Scholar
  90. 90.
    Vinekar A, Jayadev C, Bauer N. Need for telemedicine in retinopathy of prematurity in middle-income countries: e-ROP vs KIDROP. JAMA Ophthalmol. 2015a;133:360–1.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Vinekar A, Jayadev C, Dogra M, Shetty B. Improving follow-up of infants during retinopathy of prematurity screening in rural areas. Indian Pediatr. 2016;53(Suppl 2):S151–4.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Vinekar A, Jayadev C, Mangalesh S, Shetty B, Vidyasagar D. Role of tele-medicine in retinopathy of prematurity screening in rural outreach centers in India – a report of 20,214 imaging sessions in the KIDROP program. Semin Fetal Neonatal Med. 2015b;20:335–45.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Vinekar A, Mangalesh S, Jayadev C, Gilbert C, Dogra M, Shetty B. Impact of expansion of telemedicine screening for retinopathy of prematurity in India. Indian J Ophthalmol. 2017;65:390–5.PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Von-Bischhoffshausen FB, Munoz B, Riquelme A, Ormeno MJ, Silva JC. Spectacle-wear compliance in school children in Concepcion Chile. Ophthalmic Epidemiol. 2014;21:362–9.PubMedCrossRefPubMedCentralGoogle Scholar
  95. 95.
    Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev. 2011;12:CD004916.Google Scholar
  96. 96.
    Wedner S, Masanja H, Bowman R, Todd J, Bowman R, Gilbert C. Two strategies for correcting refractive errors in school students in Tanzania: randomised comparison, with implications for screening programmes. Br J Ophthalmol. 2008;92:19–24.PubMedCrossRefPubMedCentralGoogle Scholar
  97. 97.
    Yasmin S, Minto H, Chan VF. School eye health – going beyond refractive errors. Commun Eye Health. 2015;28:14–5.Google Scholar
  98. 98.
    Yi H, Zhang H, Ma X, Zhang L, Wang X, Jin L, Naidoo K, Minto H, Zou H, Lu L, Rozelle S, Congdon N. Impact of free glasses and a teacher incentive on children’s use of eyeglasses: a cluster-randomized controlled trial. Am J Ophthalmol. 2015;160:889–96. e1PubMedPubMedCentralCrossRefGoogle Scholar
  99. 99.
    You C, Wu X, Zhang Y, Dai Y, Huang Y, Xie L. Visual impairment and delay in presentation for surgery in Chinese pediatric patients with cataract. Ophthalmology. 2011;118:17–23.PubMedPubMedCentralCrossRefGoogle Scholar
  100. 100.
    Zeng Y, Keay L, He M, Mai J, Munoz B, Brady C, Friedman DS. A randomized, clinical trial evaluating ready-made and custom spectacles delivered via a school-based screening program in China. Ophthalmology. 2009;116:1839–45.PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Zin AA, Magluta C, Pinto MF, Entringer AP, Mendes-Gomes MA, Moreira ME, Gilbert C. Retinopathy of prematurity screening and treatment cost in Brazil. Rev Panam Salud Publica. 2014;36:37–43.PubMedPubMedCentralGoogle Scholar
  102. 102.
    Zin AA, Moreira ME, Bunce C, Darlow BA, Gilbert CE. Retinopathy of prematurity in 7 neonatal units in Rio de Janeiro: screening criteria and workload implications. Pediatrics. 2010;126:e410–7.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Rohit C. Khanna
    • 1
    Email author
  • Maria Vittoria Cicinelli
    • 2
  • Vijaya K. Gothwal
    • 3
    • 4
  • Clare Gilbert
    • 5
  1. 1.L V Prasad Eye InstituteHyderabadIndia
  2. 2.Department of OphthalmologyUniversity Vita-Salute, Scientific Institute San RaffaeleMilanItaly
  3. 3.Brien Holden Eye Research CentreL V Prasad Eye InstituteHyderabadIndia
  4. 4.Meera and L B Deshpande Centre for Sight Enhancement, Institute for Vision RehabilitationL V Prasad Eye InstituteHyderabadIndia
  5. 5.International Centre for Eye Health, Department of Clinical ResearchLondon School of Hygiene & Tropical MedicineLondonUK

Personalised recommendations